NVO20250801C110
NVO Aug 1 2025 110.00 Call (NVO250801C00110000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.